Background: Semantic processing relies on temporal brain regions, including medial temporal lobe (MTL) structures, that are the first to be affected by tau pathology in Alzheimer's disease (AD). A widely used task to assess semantic memory is the category fluency. Performance on this task was demonstrated to be impaired since the prodromal stage of AD and associated to the structural integrity of the MTL. However, the associations between category fluency measures and MTL tau burden have been rarely explored at the early stages of the disease.
Method: Seventy-five participants underwent [F]MK6240 tau-PET, magnetic resonance imaging and cognitive assessment including category fluency (animals, 2 minutes). Amyloid-b (Ab) status was determined with lumbar punction or [F]Flutemetamol Aβ-PET (Ab+ for cerebrospinal fluid Ab level<437pg/ml or Centiloid≥20). Participants included 33 Ab- cognitively normal (CN), 15 Ab+ CN and 27 Ab+ MCI individuals (Table 1). In addition to the category fluency total score, the mean cluster size (cluster = group of words that are sequentially produced and all contained within a subcategory such as birds), the number of subcategories evoked (aggregating semantically related clusters), the mean size of subcategories and the number of switches between clusters were calculated. Associations between these metrics and MTL tau burden were assessed using Spearman-rank coefficients and generalized linear models adjusting for age, sex and education.
Result: Over the entire sample, associations were found between the MTL tau burden and the total score (r = -0.44, p<.001, Figure 1), the mean cluster size (r = -0.29, p = .047), and the mean size of subcategories (r = -0.40, p = .002), even when controlling for age, sex and education (b = -5.06, SE = 1.62, p = .003; b = -0.33, SE = 0.16, p = .039; b = -0.46, SE = 0.15, p = .003, respectively). The number of switches (r = -0.13, p = 1.0) and the number of subcategories (r = -0.13, p = 1.0) were not associated to the MTL tau burden.
Conclusion: MTL tau burden was equivalently associated to the category fluency total score and two metrics relying more purely on semantic memory (mean size of clusters and subcategories). Given its critical role in conceptual knowledge and its involvement in the earliest stage of tauopathy, future work will analyze the associations between tau burden in the (peri)rhinal cortex and the category fluency metrics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.095163 | DOI Listing |
Alzheimers Dement
December 2024
National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.
Background: Growing evidence suggests that the imbalance between excitability and inhibitory neural activity is a key aspect of cognitive decline. Subclinical epileptiform activity (SEA) has been indicated as a marker of increased cortical excitability. While SEA is considered as a benign EEG sign in the elderly population, recent studies demonstrated its role in the progression of Alzheimer's disease.
View Article and Find Full Text PDFBackground: Canada and the United States are both aging and becoming increasingly diverse. Despite this demographic shift, non-White racial/ethnic groups remain underrepresented in research on cognitive impairment and dementia. A major barrier to inclusivity is the lack of cognitive assessments that are valid in individuals with diverse language and cultural backgrounds.
View Article and Find Full Text PDFBackground: Gut microbiome features have been linked with many diseases including Alzheimer's disease (AD). Evidence suggests that the gut microbiota may impact cognition of AD patients. We explored the association of gut microbiota and three PACC3 cognitive scores in individuals at risk for AD.
View Article and Find Full Text PDFBackground: Mild cognitive impairment (MCI) is largely under-diagnosed by primary care physicians. There is an urgent need to develop new objective screening tools to assist with early detection of MCI. Time-domain functional near-infrared spectroscopy (TD-fNIRS) can be used to measure brain function in clinical settings and may fill this need.
View Article and Find Full Text PDFBackground: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by cognitive decline, memory loss, and impaired daily functioning. As the global population ages, the prevalence of AD continues to rise, emphasising the urgent need for effective preventive and therapeutic strategies. Carotenoids, a group of naturally occurring pigments with antioxidant properties, have gained attention for their potential neuroprotective effects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!